We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Luminex Corporation Begins Clinical Trials for ARIES™ GBS Assay

News   Jun 09, 2015

 
Luminex Corporation Begins Clinical Trials for ARIES™ GBS Assay
 
 
 

RELATED ARTICLES

Study Identifies Effective Ketamine Doses for Treatment-Resistant Depression

News

Study identifies two subanesthetic dosage levels of the anesthetic drug ketamine that appear to provide significant symptom relief to patients with treatment-resistant depression.

READ MORE

Paralysis from Rare Disorder: Stem Cell Therapy Trial Brings Hope

News

A clinical trial is planned to see if a single injection of progenitor cells can help repair spinal cords inflamed by transverse myelitis.

READ MORE

Gene Therapy Trial a Success in Treating Rare Form of Blindness

News

Results are out from the world’s first gene therapy trial for a genetic cause of blindness, known as choroideremia.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE